Beyond tissue.

Beyond mechanical.

Beyond long lasting.

BEYOND COMPARE.

Tria heart valves are made with revolutionary new LifePolymer™ material and designed to last a lifetime. Our goal is to help millions of patients with aortic, mitral, and tricuspid valve disease receive cost-effective treatment in a single heart valve procedure.

Tria heart valves are investigational devices that are not available for sale.

Heart Valve

Key advantages of Tria Heart valves

Heart Vavle

  • Combines LifePolymer™—an advanced biopolymer material—and a patented design that makes it possible to develop long-lasting heart valves, without any animal tissue
  • Developed to replace diseased aortic, mitral, and tricuspid valves
  • Designed to reduce or eliminate the need for a lifetime of anticoagulant drugs, including their risks and side effects
  • Provides a larger orifice area than conventional hand-stitched valves, intended to create hemodynamics and blood flow similar to natural human heart valves
  • Capable of being used in transcatheter or surgical applications
  • Robotically manufactured to provide the highest level of quality and precision, while eliminating the variability of human production

LEARN HOW FOLDAX IS LAYING THE GROUNDWORK FOR THE CLINICAL USE OF ITS INNOVATIVE HEART VALVE

Foldax Presentation during the Innovation Session at TCT2019

WATCH VIDEO

Foldax’s LifePolymer™ Development Partner has Deep Expertise in Polymer Development

READ PRESS RELEASE

Video

About Foldax

Foldax, Inc. is the leader in the development of biopolymeric heart valves with the goal of improving hemodynamic performance similar to natural human valves. Driven by a passion to help patients, we collaborate with leading clinicians and researchers to design and manufacture heart valves intended to provide sustainable quality of life improvement for people with aortic, mitral or tricuspid valve disease.

CONTACT

* Denotes required field

[honeypot website1 move-inline-css:true]